Browse studies
Find your next paid study
16 recruiting studies matching your filters
Phase 1
A Phase Ib/II Open-Label, Dose-Escalation, Safety, Pharmacokinetic, Pharmacodynamic and Efficacy Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma
This is a Phase Ib/II, open-label, single institution dose-escalation, safety, pharmacokinetics, pharmacodynamic and efficacy study.
Advanced Lung Adenocarcinoma
The University of Texas Health Science Center at San AntonioNCT06516887
Phase 1
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
This is a multi-center, first-in-human, open label, dose escalation (Part A) and expansion (Part B) Phase 1 study in subjects with advanced solid tumors and in…
Advanced Solid TumorNSCLC (Non-small Cell Lung Cancer)Renal Cancer+3 more
Nuvectis Pharma, Inc.NCT05873686
Observational
Engagement of Veterans With Lung Cancer (EVLC)
This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
Lung Cancer (NSCLC)Lung AdenocarcinomaLung Cancer, Non-Small Cell+3 more
Palo Alto Veterans Institute for ResearchNCT07219251
Phase 1
An Open-Label Safety and Tolerability Pilot Study of Dapagliflozin in Stage IA Lung Adenocarcinoma
This early phase I trial tests the safety and side effects of dapagliflozin given prior to surgery in patients with stage IA lung adenocarcinoma. Dapagliflozin…
Lung AdenocarcinomaStage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8Stage IA2 Lung Cancer AJCC v8+2 more
Jonsson Comprehensive Cancer CenterNCT07235280